Show results for
Refine by
Radiotherapy Effect Equipment & Supplies
7 equipment items found
Manufactured by:Panacea Medical Technologies Pvt. Ltd. based inKolar, INDIA
Bhabhatron MLC addresses these important attributes in treating cancer patients, ensuring focussed & precisely targeted treatment. Intuitive Workflow: Efficient workflow is the key in today’s radiotherapy clinics. Bhabhatron MLC brings together all the major elements from planning to treatment delivery seamlessly for an effective radiation therapy ...
Manufactured by:Panacea Medical Technologies Pvt. Ltd. based inKolar, INDIA
Healthcare facilities are constantly changing to extend high quality & affordable care by providing an efficient treatment solution to whom it really Matters: The Patients. Bhabhatron II addresses these important attributes in treating cancer patients, ensuring focussed & precisely targeted ...
Manufactured by:Hybio Pharmaceutical Co., Ltd. based inGuangdong, CHINA
1 mg: Hasten T cell differentiation,reinforce immune function of tumor patients; Boost NK cell cytoactivity,two-ways regulation of immune function in case of active hepatitis; Contain virus replication,treat chroic Hepatitis B; Used both in IV drop and intramuscular injection. 10 mg: Particlarly indicated for adjuvant therapy of malignant carcinoma cases under chemotherapy & ...
Manufactured by:BetaGlue Technologies SpA based inMilano, ITALY
Surgery is the standard of care for resectable solid tumors. Loco-regional approaches, in combination with chemotherapy and/or radiotherapy, are standard therapy in the following ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Teglarinad chloride (GMX1777) is a proagent of GMX1778 (a nicotinamide phosphoribosyl transferase inhibitor). Teglarinad chloride exhibits antitumor activity in mice can be attributed to inhibition of NAMPT. Teglarinad chloride also enhances radiation efficacy, mediated by interference with DNA repair and ...
by:Aphios Corporation based inWoburn, MASSACHUSETTS (USA)
Prostate cancer is the most prevalent cancer among men, and it is the second leading cause of cancer death among men in the United States. More than 500,000 cases are diagnosed annually. In the U.S. this year, 1 in 6 males will develop the disease and 30,000 others will die of it. Although prostate cancer mostly affects elderly men, the number of younger men with prostatic carcinoma is ...
by:Sensus Healthcare, Inc. based inBoca Raton, FLORIDA (USA)
By delivering a precise, calibrated dose of Superficial Radiation Therapy that only goes skin deep, patients can be safely treated right in their physician’s office. Each treatment is virtually painless. Low-dose Superficial Radiation Therapy effectively destroys basal cell carcinoma and squamous cell carcinoma, as well as the non-malignant tumor cells that cause keloids. Best of all, it ...